Perspectives in dermatopathology. The revised European-American classification of lymphoid neoplasms (REAL): A new perspective for the classification of cutaneous lymphomas

Journal of Cutaneous Pathology

Volumn 24, Issue 6, 1997, Pages 329-341

  Sander, Christian A ^a   Kind, Peter ^a   Kaudewitz, Peter ^a   Raffeld, Mark ^b   Jaffe, Elaine S ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; EUROPE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; REVIEW; SKIN LYMPHOMA; UNITED STATES; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CLASSIFICATION; FOLLICULAR LYMPHOMA; HUMAN; LYMPHOCYTOMA; SEZARY SYNDROME; SKIN TUMOR; T CELL LYMPHOMA;

HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, SMALL LYMPHOCYTIC; LYMPHOMA, T-CELL; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 0031183979     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb00801.x     Document Type: Review

References (93)

1. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992: 52: 5432s.
2. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. Cancer 1982: 49: 2112.
3. Gerard-Marchant R, Hamlin I, Lennert K, et al. Classification of non-Hodgkin's lymphomas. Lancet 1974: ii: 406.
4. Lennert K, Feller A, Histopathology of non-Hodgkin's lymphomas. 2nd edn. New York: Springer-Verlag, 1992.
5. Lukes R, Collins R. Immunologic characterization of human malignant lymphomas. Cancer 1974: 34: 1488.
6. Stansfeld A, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988: i: 292.
7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. [see comments] Blood 1994: 84: 1361.
8. Isaacson P, Norton AJ. General features of extranodal lymphoma. In: Isaacson P, Norton AJ, eds. Extranodal Lymphomas. Edinburgh: Churchill Livingstone, 1994: 1.
9. Jaffe ES. The elusive Reed-Sternberg cell. (editorial) N Engl J Med 1989: 320: 529.
10. Jaffe ES, Zarate OA, Kingma DW, Raffeld M, Medeiros LJ. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol 1994: 5: S7.
11. Sander CA, Medeiros LJ, Abruzzo LV, Horak ID, Jaffe ES. Lymphoblastic lymphoma presenting in cutaneous sites: a clinicopathologic analysis of six cases. J Am Acad Dermatol 1991: 25: 1023.
12. Link M, Roper M, Dorfman R, et al. Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983: 61: 838.
13. Burg G, Kaudewitz P, Klepzig K, Przybilla B, Braun-Falco O. Cutaneous B-cell lymphoma. Dermatol Clin 1985: 3: 689.
14. Wood GS, Burke JS, Horning S, et al. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. Blood 1983: 62: 464.
15. Garcia CF, Weiss LM, Warnke RA, Wood GS. Cutaneous follicular lymphoma. Am J Surg Pathol 1986: 10: 454.
16. Cerroni L, Volkenandt M, Rieger E, Soyer HP, Kerl H. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994: 102: 231.
17. Neri A, Fracchiolla NS, Roscetti E, et al. Molecular analysis of cutaneous B- and T-cell lymphomas. Blood 1995: 86: 160.
18. Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer 1991: 67: 2311.
19. Piccinno R, Caccialanza M, Berti E, Baldini L. Radiotherapy of cutaneous B cell lymphomas: our experience in 31 cases. Int J Radiat Oncol Biol Phys 1993: 27: 385.
20. Cerroni L, Zenahlik P, Hofler G, et al. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia - a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 1996: 20: 1000.
21. Isaacson P, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathol 1987: 11: 445.
22. Rijlaarsdam JU, van der Putte SC, Berti E, et al. Cutaneous immunocytomas: a Clinicopathologic study of 26 cases. Histopathology 1993: 23: 117.
23. LeBoit PE, McNutt NS, Reed JA, Jacobson M, Weiss LM. Primary cutaneous immunocytoma. A B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol 1994: 18: 969.
24. Slater DN. MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease. [see comments] Br J Dermatol 1994: 131: 557.
25. Bailey EM, Ferry JA, Harris NL, et al. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol 1996: 20: 1011.
26. van der Putte SC, Toonstra J, Schuurman HJ, van Unnik JA. Immunocytoma of the skin simulating lymphadenosis benigna cutis. Arch Dermatol Res 1985: 277: 36.
27. Schmid U, Eckert F, Griesser H, et al. Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells. A clinicopathologic study of 18 patients. Am J Surg Pathol 1995: 19: 12.
28. Sander C, Kaudewitz P, Schirren C, Jaffe E, Kind P. Immunocytoma and marginal zone B-cell lymphoma (MALT lymphoma) presenting in skin - different entities or a spectrum of disease. J Cutan Pathol 1996: 23: 59a.
29. Hussell T, Isaacson P, Crabtree J, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993: 342: 571.
30. Garbe C, Stein H, Dienemann D, Orfanos CE. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991: 24: 584.
31. Sander C, Kaudewitz P, Kutzner H, et al. T-cell-rich-B-cell lymphoma presenting in skin. J Cutan Pathol 1996: 23: 101.
32. Willemze R, Meijer CJ, Scheffer E, et al. Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients. Am J Pathol 1987: 126: 325.
33. Kurtin PJ, DiCaudo DJ, Habermann TM, Chen MG, Su WP. Primary cutaneous large cell lymphomas. Morphologic, immunophenotypic, and clinical features of 20 cases. Am J Surg Pathol 1994: 18: 1183.
34. DiGiuseppe JA, Nelson WG, Seifter EJ, Boitnott JK, Mann RB. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 1994: 12: 2573.
35. Bertero M, Novelli M, Fierro MT, Bernengo MG. Mantle zone lymphoma: an immunohistologic study of skin lesions. J Am Acad Dermatol 1994: 30: 23.
36. Geerts ML, Busschots AM. Mantle-cell lymphomas of the skin. Dermatol Clin 1994: 12: 409.
37. Banks P, Chan J, Cleary M, et al. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992: 16: 637.
38. Raffeld M, Sander CA, Yano T, Jaffe ES. Mantle cell lymphoma: an update. Leuk Lymphoma 1992: 8: 161.
39. Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell derived neoplasms. Blood 1991: 78: 259.
40. Kumar S, Krenacs L, Otsuki T, et al. bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 1996: 105: 737.
41. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994: 145: 86.
42. Ellison DJ, Turner RR, Van Antwerp R, Martin SE, Nathwani BN. High-grade mantle zone lymphoma. Cancer 1987: 60: 2717.
43. Waldron J, Leech J, Glick A, Glexner J, Collins R. Malignant lymphoma of peripheral T-lymphocyte origin: Immunologic, pathologic and clinical features in 6 patients. Cancer 1977: 40: 1604.
44. Jaffe ES. Post-thymic T-cell lymphomas. In: Jaffe ES, eds. Surgical Pathology of the Lymph Nodes and Related Organs. Philadelphia: W. B. Saunders, 1995: 344.
45. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991: 15: 17.
46. Burg C, Dummer R, Wilhelm M, et al. A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. [see comments] N Engl J Med 1991: 325: 1078.
47. Kaudewitz P, Burg G, Stein H. Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. Curr Probl Dermatol 1990: 19: 150.
48. Siegert W, Nerl C, Agthe A, et al. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. Ann Oncol 1995: 6: 659.
49. Lutzner M, Edelson R, Schein P, et al. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975: 83: 534.
50. Armitage J, Greer J, Levine A, et al. Peripheral T-cell lymphoma. Cancer 1989: 63: 158.
51. Coiffier B, Berger F, Bryon P, Magaud J. T-cell lymphomas: immunologic, histologic, clinical, and therapeutic analsis of 63 cases. J Clin Oncol 1988: 6: 1584.
52. Horning S, Weiss L, Crabtree G, Warnke R. Clinical and phenotypic diversity of T-cell lymphomas. Blood 1986: 67: 1578.
53. Hastrup N, Hamilton-Dutoit S, Ralfkiaer E, Pallesen G. Peripheral T-cell lymphomas: an evaluation of reproducibility of the updated Kiel classification. Histopathology 1991: 18: 99.
54. Noorduyn LA, Van der Valk P, Van Heerde P, et al. Stage is a better prognostic indicator than morphologic subtype in primary non-cutaneous T-cell lymphoma. Am J Clin Pathol 1990: 93: 49.
55. Frizzera G, Kaneko Y, Sakurai M. Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions. Leukemia 1989: 3: 1.
56. Siegert W, Agthe A, Griesser H, et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/ IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med 1992: 117: 364.
57. Jaffe ES. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains. [editorial] Ann Oncol 1995: 6: 631.
58. de Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 1993: 23: 127.
59. Paulli M, Berti E, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin - clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1995: 13: 1343.
60. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 1993: 71: 2097.
61. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993: 28: 973.
62. McCarty MJ, Vukelja SJ, Sausville EA, et al. Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. A report of two cases and a review of the literature. Cancer 1994: 74: 3051.
63. Kaudewitz P, Kind P, Sander C. CD30+ anaplastic large cell lymphoma. Semin Dermatol 1994: 13: 180.
64. Weiss LM, Wood GS, Trela M, Warnke RA, Sklar J. Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986: 315: 475.
65. Krishnan J, Tomaszewski M, Kao G. Primary cutaneous CD30-positive anaplastic large cell lymphoma - report of 27 cases. J Cutan Pathol 1993: 20: 193.
66. Wellman A, Otsuki T, Vogelbruch M, et al. Analysis of the t(2;5) (p23;q35) translocation by reverse trasnscription-polymerase chain reaction in CD 30+ anaplastic large-cell lymphomas, in other non-Hodgkin's of T-cell phenotype, and in Hodgkin's disease. Blood 1995: 86: 2321.
67. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996: 87: 3437.
68. Beylot-Barry M, Lamant L, Vergier B, et al. Detection of t(2;5) (p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996: 149: 483.
69. Emile J-F, Boulland M-L, Haioun C, et al. CD5- CD 56+ "TCR silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996: 87: 1466.
70. Chan JK, Ng CS, Ngan KC, et al. Angiocentric T-cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides. Am J Surg Pathol 1988: 12: 861.
71. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996: 20: 103.
72. DeRemee RA, Weiland LH, McDonald TJ. Polymorphic reticulosis and lymphomatoid granulomatosis: two diseases or one. Mayo Clin Proc 1978: 53: 634.
73. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T cell proliferations. Blood 1988: 5: 1674.
74. Guinee DJ, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 1994: 18: 753.
75. Myers JL, Kurtin PJ, Katzenstein AL, et al. Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol 1995: 19: 1300.
76. Perniciaro C, Zalla MJ, White JW, Menke DM. Subcutaneous T-cell lymphoma: Report of two additional cases and further observations. Arch Dermatol 1993: 129: 1171.
77. Romero LS, Goltz RW, Nagi C, Shin SS, Ho AD. Subcutaneous T-cell lymphoma with associated hemophagocytic syndrome and terminal leukemic transformation. J Am Acad Dermatol 1996: 34: 904.
78. Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, Geisler C, Vejlsgaard GL. T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study. Exp Dermatol 1992: 1: 31.
79. Jaffe ES, Blattner WA, Blayney DW, et al. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Am J Surg Pathol 1984: 8: 263.
80. Levine PH, Cleghorn F, Manns A, et al. Adult T-cell leukemia/lymphoma: a working point-score classification for epidemiological studies. Int J Cancer 1994: 59: 491.
81. Levine PH, Manns A, Jaffe ES, et al. The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States. Int J Cancer 1994: 56: 177.
82. Waldmann TA, White JD, Goldman CK, et al. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 1993: 82: 1701.
83. Hall WW. Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma. [published erratum appears in J Exp Med 1995: 181(1): 441] J Exp Med 1994: 180: 1581.
84. Manca N, Piacentini E, Gelmi M, et al. Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides. [published erratum appears in J Exp Med 1995: 181(1): 441] J Exp Med 1994: 180: 1973.
85. Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991: 78: 3269.
86. Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood 1995: 86: 1163.
87. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. [see comments] Br J Haematol 1990: 75: 49.
88. Jaffe ES. Classification of NK-cell and NK-like T-cell malignancies. (Editorial) Blood 1996: 87: 1207.
89. Kumar S, Kingma DW, Weiss WB, Raffeld M, Jaffe ES. Primary cutaneous Hodgkin's disease with evolution to systemic disease. Association with the Epstein-Barr virus. Am J Surg Pathol 1996: 20: 754.
90. Sioutos N, Kerl H, Murphy S, Kadin M. Primary cutaneous Hodgkin's disease: unique clinical, morphological, and immunophenotypic findings. Am J Dermatopathol 1994: 16: 2.
91. Sander C, Medeiros L, Gerl A, et al. Nodular sclerosing Hodgkin's disease involving skin. J Cutan Pathol 1993: 20: 567a.
92. Mason D, Banks P, Chan J, et al. Nodular lymphocyte predominance Hodgkin's disease: a distinct clinico-pathological entity. Am J Surg Pathol 1994: 18: 528.
93. Jaffe E. Classification of cutaneous lymphomas: REAL vs. Un-REAL. Ann Oncol 1996: 7: 14a.